About Genx Diagnostics Limited
Data last updated: 08 January 2026
Genx Diagnostics Limited is a public limited company based in Bhubaneswar, Orissa, India. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 24 February 2016, the company has been in operation for over 10 years.
Registered with ROC Cuttack under CIN U85195OR2016PLC019956.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.12 Cr. It is led by directors including Suryaprakasam Vedam Lakshmi Ramprasad and Surajit Chakrabartty.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.1 Bda Chandrashekharpur District Centre, Bhubaneswar, Orissa, India – 751016.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.97 Cr, a growth of 17% compared to the previous year.
The company has a workforce of approximately 144 employees as per the latest available data.
The company is associated with 1 brand - Genx Diagnostics. As per MCA filings, the company has open charges of ₹15.23 Cr and satisfied charges of ₹5.55 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genxlive.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Apps
-
Registered AddressPlot No.1 Bda Chandrashekharpur District Centre, Bhubaneswar, Orissa, India – 751016
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Genx Diagnostics Limited
Genx Diagnostics Limited has one previous CIN (Corporate Identification Number): U85195OR2016PTC019956. The current CIN is U85195OR2016PLC019956, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85195OR2016PLC019956 | Current |
| U85195OR2016PTC019956 | Previous |
Associated Brands with Genx Diagnostics Limited
Genx Diagnostics Limited operates one associated brand: GenX Diagnostics. These brands represent Genx Diagnostics Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Diagnostic services including clinical testing and imaging in Odisha. | genxlive.in |
Business Activity of Genx Diagnostics Limited
Genx Diagnostics Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | ********* |
Auditor Details of Genx Diagnostics Limited
Genx Diagnostics Limited is audited by RAJESH BISWANATH & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJESH BISWANATH & CO | blur-value | blur-value | blur-value |
Board of Directors of Genx Diagnostics Limited
Genx Diagnostics Limited is currently managed by 3 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Suryaprakasam Vedam Lakshmi Ramprasad
Also directs:
Genx Diagnostics Limited, Medgenome Labs Limited, Green Cross Genetics Lab Private Limited and 4 more
|
Director | 21 Aug 2024 | 1 Years 10 Months | Current |
|
Surajit Chakrabartty
Also directs:
Genx Diagnostics Limited, Ekavidha Corporate Services Private Limited, Medgenome Labs Limited and 5 more
|
Director | 21 Aug 2024 | 1 Years 10 Months | Current |
| Biswajit Mohanty | Managing Director | 24 Feb 2016 | 10 Years 4 Months | Current |
Financials of Genx Diagnostics Limited FY 2025 filings available
Genx Diagnostics Limited reported revenue of ₹36.97 Cr (up 17% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Genx Diagnostics Limited
As of FY 2023, Genx Diagnostics Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Genx Diagnostics Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2022 | Hdfc Bank Limited | ₹1.44 Cr | Open |
| 15 Jan 2022 | Hdfc Bank Limited | ₹3.78 Cr | Open |
| 20 Dec 2021 | Hdfc Bank Limited | ₹2.52 Cr | Open |
| 07 Dec 2021 | Others | ₹5.25 Cr | Open |
| 04 Dec 2018 | Hdfc Bank Limited | ₹2.24 Cr | Open |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Genx Diagnostics Limited
Genx Diagnostics Limited has a workforce of 144 employees as of Apr 08, 2024.
Employee Count & EPFO Data of Genx Diagnostics Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Genx Diagnostics Limited
GSTIN & GST Filing Data of Genx Diagnostics Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Genx Diagnostics Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Genx Diagnostics Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Genx Diagnostics Limited
MSME Payment Delays by Genx Diagnostics Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Genx Diagnostics Limited
Subsidiaries & Group Companies of Genx Diagnostics Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Genx Diagnostics Limited with ownership details.
MCA Filings & Documents of Genx Diagnostics Limited
MCA Filings & Documents of Genx Diagnostics Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Genx Diagnostics Limited
Frequently Asked Questions about Genx Diagnostics Limited
Genx Diagnostics Limited is an active public limited company in the healthcare sector based in Bhubaneswar, Orissa, India. It was incorporated on 24 February 2016 (10+ years old) and is registered under CIN U85195OR2016PLC019956. The company has 144 employees.
Genx Diagnostics Limited reported revenue of ₹36.97 Cr for FY 2025 (up 17.00% YoY).
The current directors of Genx Diagnostics Limited are:
The primary industry of Genx Diagnostics Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Genx Diagnostics Limited can be reached at the registered office: Plot No.1 Bda Chandrashekharpur District Centre, Bhubaneswar, Orissa, India – 751016, or through the website genxlive.in.
The authorised capital is ₹10 Cr, and the paid-up capital is ₹7.12 Cr.